Oscar Health, Inc. (NYSE:OSCR) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Cornelia Miller - Vice President, Corporate Development and Investor Relations Mario Schlosser - Co-Founder and Chief Executive Officer Scott Blackley - Chief Financial Officer Sid Sankaran - Interim Chief Financial Officer Conference Call Participants Connor Massari - Morgan Stanley Stephen Baxter - Wells Fargo Nathan Rich - Goldman Sachs Josh Raskin - Nephron Research Operator Good afternoon. M ...

Oscar Health, Inc. (NYSE:OSCR) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Cornelia Miller - Vice President of Corporate Development & Investor Relations Mario Schlosser - Co-Founder & Chief Executive Officer Scott Blackley - Chief Financial Officer Conference Call Participants Michael Hall - Morgan Stanley Stephen Baxter - Wells Fargo Securities Jonathan Yong - Credit Suisse Kevin Fischbeck - Bank of America Josh Raskin - Nephron Research Lindsay Golub - Goldman Sachs O ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________to__________ Commission File Number: 001-40154 ____________________________________________________________ Oscar Health, Inc. (Exact name of registrant as specified in its charter) | Delaware | ____________________________________________________________ | 46-1315570 | | -- ...

Oscar Health, Inc. Second Quarter 2022 Earnings Presentation August 11, 2022 HIOSCAR.COM Safe Harbor Statement and Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained herein are forward-looking statements. These statements include, but are not limited to, statements about our financial outlook and estimates, including direct and assumed po ...

Oscar Health, Inc. First Quarter 2022 Earnings Presentation May 10, 2022 HIOSCAR.COM Safe Harbor Statement and Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained herein are forward-looking statements. These statements include, but are not limited to, statements about our financial outlook and estimates, including direct and assumed policy ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________to__________ Commission File Number: 001-40154 ____________________________________________________________ Oscar Health, Inc. (Exact nam ...

Oscar Health Inc. (NYSE:OSCR) Q1 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Mario Schlosser - Co-Founder and CEO Cornelia Miller - VP-Corporate Development and IR Scott Blackley - CFO Conference Call Participants Ricky Goldwasser - Morgan Stanley Stephen Baxter - Wells Fargo Jonathan Yong - Credit Suisse Gary Taylor - Cowen Joshua Raskin - Nephron Research Nathan Rich - Goldman Sachs Operator Good afternoon. My name is Christian and I will be your conference operator for toda ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________to__________ Commission File Number: 001-40154 ____________________________________________________________ Oscar Health, Inc. (Exact name of ...

Oscar Health, Inc. Fourth Quarter and Full Year 2021 Earnings Presentation February 10, 2022 HIOSCAR.COM Safe Harbor Statement and Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained herein are forward-looking statements. These statements include, but are not limited to, statements about our financial outlook and estimates, including direc ...

Oscar Health Inc. (NYSE:OSCR) Q4 2021 Earnings Conference Call February 10, 2022 5:00 PM ET Company Participants Mario Schlosser – Co-Founder and Chief Executive Officer Cornelia Miller – Vice President-Corporate Development and Investor Relations Scott Blackley – Chief Financial Officer Conference Call Participants Marianne Scott – Scott Health Consulting Ricky Goldwasser – Morgan Stanley Adam Ronn – Bank of America Stephen Baxter – Wells Fargo Jonathan Yong – Credit Suisse Josh Raskin – Nephron Nathan Ric ...